These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29809131)

  • 1. Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.
    Tauziède-Espariat A; Saffroy R; Pagès M; Pallud J; Legrand L; Besnard A; Lacombe J; Lot G; Borha A; Tazi S; Adle-Biassette H; Polivka M; Lechapt E; Varlet P
    Clin Neuropathol; 2018; 37(5):209-216. PubMed ID: 29809131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3F3A K27M mutations in thalamic gliomas from young adult patients.
    Aihara K; Mukasa A; Gotoh K; Saito K; Nagae G; Tsuji S; Tatsuno K; Yamamoto S; Takayanagi S; Narita Y; Shibui S; Aburatani H; Saito N
    Neuro Oncol; 2014 Jan; 16(1):140-6. PubMed ID: 24285547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases.
    Zheng L; Gong J; Yu T; Zou Y; Zhang M; Nie L; Chen X; Yue Q; Liu Y; Mao Q; Zhou Q; Chen N
    Am J Surg Pathol; 2022 Jun; 46(6):863-871. PubMed ID: 35416795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct molecular profile of diffuse cerebellar gliomas.
    Nomura M; Mukasa A; Nagae G; Yamamoto S; Tatsuno K; Ueda H; Fukuda S; Umeda T; Suzuki T; Otani R; Kobayashi K; Maruyama T; Tanaka S; Takayanagi S; Nejo T; Takahashi S; Ichimura K; Nakamura T; Muragaki Y; Narita Y; Nagane M; Ueki K; Nishikawa R; Shibahara J; Aburatani H; Saito N
    Acta Neuropathol; 2017 Dec; 134(6):941-956. PubMed ID: 28852847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
    Lee J; Solomon DA; Tihan T
    J Neurooncol; 2017 Mar; 132(1):1-11. PubMed ID: 28064387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
    Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticator.
    Ryba A; Özdemir Z; Nissimov N; Hönikl L; Neidert N; Jakobs M; Kalasauskas D; Krigers A; Thomé C; Freyschlag CF; Ringel F; Unterberg A; Dao Trong P; Beck J; Heiland DH; Meyer B; Vajkoczy P; Onken J; Stummer W; Suero Molina E; Gempt J; Westphal M; Schüller U; Mohme M
    Neuro Oncol; 2024 Aug; 26(8):1479-1493. PubMed ID: 38507506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathology of Gliomas.
    Galbraith K; Snuderl M
    Clin Lab Med; 2024 Jun; 44(2):149-159. PubMed ID: 38821638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.
    Sievers P; Sill M; Schrimpf D; Stichel D; Reuss DE; Sturm D; Hench J; Frank S; Krskova L; Vicha A; Zapotocky M; Bison B; Castel D; Grill J; Debily MA; Harter PN; Snuderl M; Kramm CM; Reifenberger G; Korshunov A; Jabado N; Wesseling P; Wick W; Solomon DA; Perry A; Jacques TS; Jones C; Witt O; Pfister SM; von Deimling A; Jones DTW; Sahm F
    Neuro Oncol; 2021 Jan; 23(1):34-43. PubMed ID: 33130881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K27M mutant glioma: Disease definition and biological underpinnings.
    Saratsis AM; Knowles T; Petrovic A; Nazarian J
    Neuro Oncol; 2024 May; 26(Supplement_2):S92-S100. PubMed ID: 37818718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary spinal cord gliomas: Pathologic features associated with prognosis.
    Tanaka Y; Natsumeda M; Ohashi M; Saito R; Higa N; Akahane T; Hashidate H; Ito J; Fujii S; Sasaki A; Tanimoto A; Hanaya R; Watanabe K; Oishi M; Kawashima H; Kakita A
    J Neuropathol Exp Neurol; 2024 Jul; ():. PubMed ID: 39074166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
    Rodriguez FJ; Vizcaino MA; Lin MT
    J Mol Diagn; 2016 Sep; 18(5):620-634. PubMed ID: 27444975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity.
    Eschbacher KL; Ida CM; Johnson DR; Alvi MA; Jenkins SM; Ruff MW; Kerezoudis P; Neth BJ; Pasion RM; Daniels DJ; Kizilbash SH; Raghunathan A
    Am J Surg Pathol; 2021 Aug; 45(8):1082-1090. PubMed ID: 33606385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.
    Vanan MI; Underhill DA; Eisenstat DD
    Neurotherapeutics; 2017 Apr; 14(2):274-283. PubMed ID: 28233220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor.
    Sprinzen L; Garcia F; Mela A; Lei L; Upadhyayula P; Mahajan A; Humala N; Manier L; Caprioli R; Quiñones-Hinojosa A; Casaccia P; Canoll P
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.
    Graham MS; Mellinghoff IK
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.
    Ali RH; Almanabri M; Ali NY; Alsaber AR; Khalifa NM; Hussein R; Alateeqi M; Mohammed EMA; Jama H; Almarzooq A; Benobaid N; Alqallaf Z; Ahmed AA; Bahzad S; Almurshed M
    J Clin Pathol; 2024 Jan; ():. PubMed ID: 38195220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature.
    Raghu ALB; Chen JA; Valdes PA; Essayed W; Claus E; Arnaout O; Smith TR; Chiocca EA; Peruzzi PP; Bernstock JD
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Druggable genomic landscapes of high-grade gliomas.
    Ghanem P; Fatteh M; Kamson DO; Balan A; Chang M; Tao J; Blakeley J; ; Canzoniero J; Grossman SA; Marrone K; Schreck KC; Anagnostou V
    Front Med (Lausanne); 2023; 10():1254955. PubMed ID: 38143440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Landscape of Histone-Mutant Pediatric High-Grade Gliomas: A Study in Partner Alterations.
    Lubanszky E; Hawkins C
    Cancer Discov; 2023 Jul; 13(7):1516-1517. PubMed ID: 37416991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.